| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
134,770,000 |
| Market
Cap: |
25.50(B) |
| Last
Volume: |
379,697 |
Avg
Vol: |
1,122,870 |
| 52
Week Range: |
$150.33 - $192.35 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 226 |
| Guru Rank Value : 6.9 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
38,118 |
62,614 |
157,938 |
264,629 |
| Total Sell Value |
$7,127,748 |
$11,406,535 |
$27,342,776 |
$43,624,527 |
| Total People Sold |
3 |
5 |
8 |
9 |
| Total Sell Transactions |
5 |
11 |
28 |
41 |
| End Date |
2025-08-31 |
2025-05-30 |
2024-11-29 |
2023-11-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Gregg Vicky B |
Director |
|
2025-11-25 |
4 |
S |
$191.76 |
$239,700 |
D/D |
(1,250) |
17,037 |
|
- |
|
Davis J. E. |
CEO and President |
|
2025-11-25 |
4 |
AS |
$191.59 |
$10,589,760 |
D/D |
(55,093) |
120,480 |
|
- |
|
Davis J. E. |
CEO and President |
|
2025-11-25 |
4 |
OE |
$95.80 |
$5,277,634 |
D/D |
55,093 |
175,573 |
|
- |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-11-18 |
4 |
AS |
$187.35 |
$1,488,683 |
D/D |
(7,946) |
7,530 |
|
3% |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-11-18 |
4 |
OE |
$143.33 |
$1,147,845 |
D/D |
7,946 |
15,476 |
|
- |
|
Davis J. E. |
CEO and President |
|
2025-11-05 |
4 |
D |
$175.57 |
$1,254,097 |
D/D |
(7,143) |
120,480 |
|
- |
|
Pfeiffer Gary M |
Director |
|
2025-10-22 |
4 |
S |
$182.40 |
$270,317 |
D/D |
(1,482) |
29,431 |
|
-5% |
|
Gregg Vicky B |
Director |
|
2025-10-21 |
4 |
A |
$189.08 |
$13,236 |
D/D |
70 |
18,287 |
|
- |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2025-10-21 |
4 |
A |
$189.08 |
$2,836 |
D/D |
15 |
7,530 |
|
- |
|
Samad Samer Abdul |
Executive Vice President & CFO |
|
2025-10-21 |
4 |
A |
$189.08 |
$12,858 |
D/D |
68 |
25,741 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-10-21 |
4 |
A |
$189.08 |
$2,836 |
D/D |
15 |
8,379 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-10-21 |
4 |
A |
$189.08 |
$8,698 |
D/D |
46 |
15,333 |
|
- |
|
Carter Robert B |
Director |
|
2025-10-21 |
4 |
A |
$189.09 |
$1,135 |
D/D |
6 |
2,698 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-26 |
4 |
AS |
$187.22 |
$42,706 |
D/D |
(227) |
38,117 |
|
1% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-26 |
4 |
OE |
$103.57 |
$23,510 |
D/D |
227 |
38,344 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-24 |
4 |
AS |
$187.02 |
$32,729 |
D/D |
(175) |
38,117 |
|
2% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-24 |
4 |
OE |
$103.57 |
$18,125 |
D/D |
175 |
38,292 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-23 |
4 |
AS |
$187.12 |
$5,293,313 |
D/D |
(28,288) |
38,117 |
|
2% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2025-09-23 |
4 |
OE |
$103.57 |
$2,929,788 |
D/D |
28,288 |
66,405 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-21 |
4 |
AS |
$185.00 |
$365,375 |
D/D |
(1,975) |
15,269 |
|
4% |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-19 |
4 |
AS |
$183.00 |
$829,356 |
D/D |
(4,532) |
17,244 |
|
5% |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-19 |
4 |
OE |
$112.17 |
$508,354 |
D/D |
4,532 |
21,776 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-15 |
4 |
AS |
$180.00 |
$355,500 |
D/D |
(1,975) |
17,244 |
|
6% |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2025-08-13 |
4 |
D |
$175.91 |
$21,637 |
D/D |
(123) |
8,338 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2025-08-06 |
4 |
AS |
$175.00 |
$968,625 |
D/D |
(5,535) |
19,219 |
|
11% |
|
833 Records found
|
|
Page 1 of 34 |
|
|